Published: Apr 22, 2026
Written by Klarity Editorial Team
Published: Apr 22, 2026

You’re probably seeing it in your practice already: patients asking about Ozempic, Wegovy, or ‘those weight-loss shots everyone’s talking about.’ Maybe it’s the patient who gained 40 pounds on olanzapine. Maybe it’s someone struggling with binge eating and depression who saw a friend lose 50 pounds on semaglutide. Or maybe you’re just noticing the headlines — 20 million Americans now taking GLP-1 medications, demand surging 600% in six years, and no signs of slowing down.
Here’s the reality: there’s a massive opportunity for psychiatrists in the GLP-1 space, and you’re better positioned than you think. You already understand behavior change, medication management, and the mental health side of obesity. You have telehealth infrastructure. And unlike primary care docs drowning in panels of 2,000+ patients, you can actually spend time with people.
But here’s the catch: if you don’t build this right, you’ll end up overwhelmed, answering the same nutrition questions at midnight, and wondering why you ever thought adding a new service line was a good idea.
This guide covers everything you need to know: why psychiatrists are uniquely suited for GLP-1 care, how to get patients without gambling thousands on marketing, what the regulations actually say (state-by-state), and most importantly — how to scale this without sacrificing your sanity.
The Patient Demand Is Real (And Growing)
Let’s start with the numbers. By 2024, roughly 4% of Americans were on GLP-1 medications, with half using them for weight loss specifically. That’s a 600% increase in obesity usage over six years. By late 2025, an estimated 6% of the population — about 20 million people — were actively taking these drugs. Tens of thousands of new patients start GLP-1 treatment every week.
The obesity epidemic (nearly 75% of Americans are overweight or obese) has created desperate demand for something that actually works. And GLP-1s do work — we’re talking 15-20% body weight loss for many patients, results that were unthinkable with older medications.
Here’s the problem: there aren’t enough obesity medicine specialists to meet this demand. Even among those who exist, most lack the bandwidth or interest in the mental health component. That’s where you come in.
Your Existing Patients Are Asking For This
A late-2023 survey across major psychiatric departments found that nearly half of psychiatrists were already prescribing or recommending Ozempic or similar drugs. Why? Because weight gain from psychiatric medications is one of the most common reasons patients stop treatment or struggle with adherence.
Think about it: how many of your patients have gained significant weight on antipsychotics, mood stabilizers, or mirtazapine? How many have metabolic syndrome brewing? How many struggle with binge eating or emotional overeating alongside their depression or anxiety?
When you can say ‘I can help you lose that weight while keeping you stable on your psychiatric meds,’ you’re addressing a pain point that most providers ignore. You’re treating the whole person, not just siloing mental and physical health.
And here’s the thing: you already have the clinical relationship and trust. Converting an existing patient to GLP-1 treatment requires no marketing spend, no cold patient acquisition, just a conversation during a medication review.
You Understand the Psychology of Weight Loss
Unlike a primary care doc rushing through 30 patients a day, or a cash-grab telehealth mill churning prescriptions, psychiatrists bring something valuable: expertise in behavior change and mental health.
Weight loss isn’t just about the medication. It’s about managing expectations, addressing body image issues, navigating the emotional side of food restriction, and monitoring for mood changes (yes, there were concerns about suicidal ideation with GLP-1s — later debunked by FDA review, but still something psychiatrists are better equipped to watch for than most providers).
Some early research even suggests GLP-1s might independently improve certain psychiatric symptoms in depression and bipolar disorder. The mechanisms aren’t fully clear, but the overlap between metabolic health and mental health is undeniable.
Your patients need someone who can recognize when rapid weight loss is triggering disordered eating patterns, when body dysmorphia is driving unrealistic goals, or when the nausea from semaglutide is being confused with anxiety symptoms.
The Business Case Is Straightforward
Here’s what patient acquisition typically costs across channels:
DIY marketing (SEO, Google Ads, directory listings): $200-500+ per qualified patient when you factor in ALL costs — agency fees, ad spend testing, staff time to handle leads, no-shows from cold inquiries, months of SEO investment before results, failed campaigns. Google Ads for mental health keywords run $15-40+ per click, and most clicks don’t convert. SEO takes 6-12 months of consistent investment before generating meaningful patient flow.
Directory listings (Psychology Today, Zocdoc): Monthly fees PLUS you compete with hundreds of other providers on the same page. Zocdoc charges $35-100+ per booking, but total monthly cost including subscription adds up fast.
Reality check: Most solo providers don’t have the expertise, budget, or patience to make DIY marketing cost-effective. You’d be spending $3,000-5,000/month on marketing with uncertain results.
Compare that to platforms like Klarity Health: you pay a standard listing fee per new patient lead (similar to Zocdoc’s per-booking model), but with major advantages:
Instead of gambling $5K/month on marketing channels that might not work, you pay only when a qualified patient actually books with you. That’s guaranteed ROI vs. throwing money into the void and hoping something sticks.
Start With Your Existing Panel
The easiest patients to convert are the ones you already see. During your next medication review or follow-up, identify patients who meet criteria:
Many of your mental health patients will qualify, especially those on medications known for weight gain. Frame it naturally: ‘I’ve noticed you’ve mentioned concerns about the weight you’ve gained on this medication. I’ve started offering weight-loss treatment with GLP-1 medications — would you be interested in discussing that?’
This approach:
Leverage Telehealth Platforms
If you want volume beyond your existing panel, joining a telehealth platform is the fastest route. Companies like Klarity, Ro, Hims & Hers, and others are investing heavily in advertising to attract patients seeking GLP-1 treatment. They funnel those inquiries to enrolled providers.
The economics make sense: instead of you spending thousands on Google Ads hoping to attract patients, these platforms do the marketing and you pay per qualified patient who books. You get instant access to patient flow without the risk of failed marketing campaigns.
What to look for in a platform:
Targeted Marketing (If You Go Independent)
If you prefer to build your own patient base, focus on:
SEO/Content:
Social Media:
Referral Relationships:
Set the Right Expectations
Whether patients come from platforms or your own marketing, be clear upfront:
This messaging attracts motivated patients who value comprehensive care, leading to better retention and word-of-mouth referrals.
The Good News: GLP-1s Are Not Controlled Substances
This is critical: GLP-1 medications like semaglutide and tirzepatide are not scheduled drugs. That means:
The federal barriers that complicate psychiatric prescribing of stimulants or benzodiazepines simply don’t apply here.
State Licensing: You Must Be Licensed Where the Patient Is Located
Like all telehealth, you need a license in the patient’s state. No shortcuts. But there are ways to make multi-state practice easier:
Interstate Medical Licensure Compact (IMLC): 42 states plus DC and Guam are members. If you hold a license in one IMLC state and want to practice in another member state, the process is streamlined (though not automatic — you still apply for each state license, but with less paperwork).
IMLC member states in our focus group: Texas, Florida, Pennsylvania, IllinoisNOT IMLC members: California, New York
Special Florida Option: Florida offers an Out-of-State Telehealth Provider Registration for physicians licensed in other states. This lets you practice telemedicine in Florida without full licensure, though with some limitations (e.g., no Schedule II controlled substances via telehealth except for psychiatric treatment). Since GLP-1s aren’t controlled, this works perfectly for weight loss practice.
Scope of Practice: MD/DO vs. PMHNP
Psychiatrists (MD/DO): Full prescriptive authority for GLP-1s in all states. No restrictions.
Psychiatric Nurse Practitioners (PMHNPs): State-dependent. Many states require physician collaboration or supervision for NP prescribing:
California: Transitioning to independence via AB 890. NPs must first practice as ‘103 NPs’ under physician protocols for 3 years, then can become independent ‘104 NPs’ starting in 2026. Until then, physician supervision required.
Texas: Strict collaboration requirement. NPs need a Prescriptive Authority Agreement with a Texas physician. One MD can supervise up to 7 NPs.
Florida: Psychiatric NPs are NOT eligible for autonomous practice (that’s limited to primary care specialties). Must have physician collaboration.
New York: Experienced NPs (3,600+ hours of practice) can practice independently without collaborative agreements. Newer NPs need physician supervision.
Pennsylvania: All NPs require collaborative agreements with physicians. No independent practice path currently.
Illinois: After 4,000 hours of practice and 250 hours of additional education, NPs can obtain Full Practice Authority (FPA) and prescribe independently.
Bottom line for PMHNPs: Check your state’s requirements. If you need a collaborating physician and don’t have one, joining a platform that provides supervision structure is your easiest path.
Why Most GLP-1 Practices Are Cash-Pay
Here’s the insurance reality: while most insurers cover GLP-1 drugs for diabetes, coverage for obesity is extremely limited. As of mid-2024, only 13 state Medicaid programs (including CA and PA) covered GLP-1s for weight loss. Many private plans explicitly exclude them.
Medicare historically hasn’t covered weight-loss drugs, though there were pilot discussions in late 2025 about changing this.
What this means: most patients pay out-of-pocket for the medications, regardless of whether they have insurance. The question is whether they pay for YOUR visits too.
The Cash-Pay Model:
Pros:
Cons:
Typical structure: Initial consult fee ($150-300), monthly subscription ($99-299) covering follow-ups and medication access, or per-visit billing.
The Insurance Model:
Pros:
Cons:
Billing options: Standard E/M codes for obesity counseling, or Medicare’s G0447 (intensive behavioral therapy for obesity, 15-minute increments).
The Hybrid Approach (Often Best):
Many psychiatrists structure it this way:
Be transparent: Clearly outline what’s covered vs. not, estimated monthly costs including medications, and options for both scenarios.
The Burnout Risk Is Real
GLP-1 patients can be demanding. They want frequent check-ins, have lots of questions about side effects and diet, and expect rapid results. If you’re not careful, you’ll end up with:
Research shows that greater schedule control and virtual practice options reduce provider burnout. But telehealth’s flexibility is a double-edged sword — without boundaries, you’re ‘always on.’
Here’s how to scale the right way:
1. Streamline Intake and Standardize Protocols
Before the first visit:
First visit protocol (30-45 minutes):
Follow-up protocol (15-20 minutes monthly initially):
Use templates for everything. Your EHR should have smart phrases for common scenarios, order sets for labs, and medication protocols for titration.
2. Delegate Ruthlessly
You don’t need to do everything:
Medical assistants or RNs can:
Health coaches or dietitians can:
Behavioral health therapists can:
3. Use Technology to Scale
Remote patient monitoring:
Asynchronous care:
Group visits:
Template documentation:
4. Set Boundaries and Control Your Schedule
Schedule control is proven to reduce burnout. Here’s how:
Dedicated time blocks: Don’t scatter GLP-1 appointments throughout your week. Maybe dedicate Tuesday and Thursday afternoons to weight-loss visits. This lets you get into a rhythm and batch similar work.
Cap your panel: Start conservatively. Maybe 20-30 active GLP-1 patients to start, see how it feels, then expand. Don’t accept every inquiry that comes in if it will overwhelm you.
Communication hours: Make it clear when you’re available for messages (e.g., ‘Portal messages reviewed weekdays 9-5, expect response within 24 business hours’). Use auto-replies after hours.
Vacation coverage: Have a backup provider (a colleague who also does GLP-1 care, or a partnership with a platform that provides coverage) so you can actually take time off.
Say no to scope creep: You’re prescribing weight-loss medication and providing medical oversight, not becoming their primary care doctor, personal trainer, and nutritionist. Set clear roles.
5. Build Retention Without Extra Work
The best practices for retention are often the least burdensome:
Monthly touchpoints: Brief but consistent follow-ups keep patients engaged. They can be 15 minutes if you’ve delegated the details to support staff.
Educational content: Create once, use forever. Record a video about ‘What to Expect in Your First Month on Semaglutide’ and send to every new patient.
Community: Group visits or a private Facebook group/online community for your patients builds support networks without requiring your constant input.
Celebrate wins: Quick recognition of milestones (10 pounds lost, fitting into old clothes, A1c improvement) builds loyalty. Your MA can flag these during chart review for you to mention.
Transparency about plateaus: Set expectations early that weight loss isn’t linear, plateaus happen, and this is long-term treatment. Reduces crisis messages when someone doesn’t lose weight for a month.
6. Monitor Your Own Well-Being
Watch for these burnout signs:
If you notice these, take action:
The goal is sustainable growth. You should be able to manage 50-100 GLP-1 patients long-term (in addition to any psychiatric practice you maintain) without feeling overwhelmed, if you’ve built the right systems.
Here’s what you need to know for the six priority states:
Licensing: Must have CA medical license (not in IMLC, so full licensure required). Telehealth must meet same standard as in-person care. Requires documented patient consent for telehealth.
NP Practice: AB 890 allows experienced NPs to become independent ‘104 NPs’ after 3 years as ‘103 NPs’ under physician supervision. First 104 NP certifications available in 2026. Until then, PMHNPs need physician collaboration.
Market: Huge population, high demand, diverse demographics. Medi-Cal covers GLP-1 for obesity as of 2024, so insured patient demand may be strong. Competition exists in metro areas but plenty of underserved regions.
Licensing: TX license required (TX is in IMLC for expedited physician licensure). Telehealth relationship can be established purely virtually if standard of care is met.
NP Practice: Strict collaboration requirement. NPs need Prescriptive Authority Agreement with TX physician (one MD can supervise up to 7 NPs). No independent practice path.
Market: High obesity rate (~35%), large rural populations with limited access. Strong demand but fewer autonomous NP options means MD-led practices dominate.
Licensing: FL license OR Out-of-State Telehealth Provider Registration (for MDs). The registration allows telemedicine practice without full FL licensure, perfect for GLP-1 since they’re non-controlled.
NP Practice: Psychiatric NPs require physician collaboration (autonomous practice limited to primary care specialties only).
Market: Large, growing population with high obesity prevalence. Many retirement communities interested in metabolic health. Limited Medicaid coverage means mostly cash-pay, but strong patient willingness to self-pay.
Licensing: NY license required (not in IMLC). Telehealth parity laws encourage virtual care.
NP Practice: Experienced NPs (3,600+ hours) can practice independently. Newer NPs need collaborative agreements.
Market: NYC has competition, but upstate and rural areas underserved. Good opportunity for telehealth to reach beyond metro areas. Medicaid doesn’t widely cover GLP-1 for obesity (as of 2024), so mix of employer insurance and cash-pay.
Licensing: PA license required (PA is in IMLC). Recently joined Nurse Licensure Compact.
NP Practice: All NPs require collaborative agreements. No independent practice despite legislative attempts.
Market: ~33% obesity rate, urban/rural split. PA Medicaid began covering GLP-1 for obesity in 2024, potentially increasing demand. Telehealth can serve rural areas effectively.
Licensing: IL license required (IL is in IMLC). Strong telehealth parity law.
NP Practice: After 4,000 hours practice and 250 hours additional education, NPs can achieve Full Practice Authority (FPA) and prescribe independently.
Market: Chicago and metro areas have services, but high statewide obesity (~32%). IL Medicaid covers GLP-1 for obesity, rare among states. Good opportunity for insurance-based practice.
The GLP-1 opportunity for psychiatrists is real, large, and growing. Demand is surging, patients are willing to pay (because insurance often won’t), and you bring a unique combination of medication management expertise and mental health insight that sets you apart.
But success requires intention:
Get patients the smart way — leverage platforms like Klarity for guaranteed patient flow without gambling on expensive marketing, or build referral networks if you prefer independence.
Understand the regulations — get properly licensed, know your scope of practice (especially if you’re an NP), and follow state-specific telehealth rules.
Choose your business model — cash-pay for simplicity, insurance for access, or hybrid for flexibility.
Build for scale without burnout — standardize your workflows, delegate ruthlessly, use technology, set boundaries, and monitor your own well-being.
This isn’t about becoming a prescription mill. It’s about meeting a genuine medical need, improving patients’ physical and mental health simultaneously, and building a sustainable, rewarding practice that leverages your skills in a high-growth market.
The providers who succeed in this space are the ones who remember: it’s still medicine, it still requires clinical judgment and compassion, and you still need to take care of yourself to take care of others.
Ready to explore GLP-1 practice without the patient acquisition gamble? Platforms like Klarity Health handle the marketing, pre-qualify patients, provide the infrastructure, and you pay only when patients actually book. Learn more about joining Klarity’s provider network and start seeing qualified GLP-1 patients this month.
Do I need special training to prescribe GLP-1s for weight loss?
No special certification is required — if you can prescribe medications, you can prescribe GLP-1s. That said, familiarizing yourself with obesity medicine basics (contraindications, titration protocols, managing side effects) is essential. Many psychiatrists pursue CME courses or obesity medicine training to build confidence, but it’s not legally required.
Can I prescribe GLP-1s off-label?
Yes. Using semaglutide (Ozempic) or other GLP-1s for obesity when they’re technically FDA-approved for diabetes is off-label prescribing, which is legal in all states. Wegovy is specifically approved for obesity. Key is informed consent, appropriate patient selection, and documentation.
What about the suicide risk concerns with GLP-1s?
In late 2023, there were reports of rare suicidal ideation possibly linked to GLP-1 drugs. The FDA reviewed data through early 2026 and found no clear causal link, even directing removal of suicide warnings from labels. As a psychiatrist, you should still monitor mood and mental health proactively — it’s one of your value-adds in this space.
How much can I realistically make from a GLP-1 practice?
Highly variable depending on cash vs. insurance, patient volume, and pricing. Cash-pay example: 50 active patients paying $200/month average (subscription model) = $10K/month revenue before expenses. Insurance-based might generate less per patient but higher volume. Platforms typically take a cut (the listing fee per patient), but eliminate your marketing costs.
How long do patients typically stay on GLP-1 treatment?
Many patients continue long-term (12+ months, often years) because weight tends to return after stopping. This creates good practice stability and recurring revenue, but also means you need systems to manage ongoing care efficiently.
What if I don’t want to give up my psychiatric practice?
You don’t have to! Many psychiatrists maintain a mixed practice — seeing mental health patients most of the week and dedicating specific time blocks to GLP-1 patients. The variety can actually reduce burnout compared to doing one thing exclusively.
Axios – ‘Just how many Americans are taking GLP-1s now’ (Fair Health data on usage), May 27, 2025. www.axios.com
ConfectioneryNews – ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry,’ October 20, 2025. www.confectionerynews.com
Time Magazine – ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny,’ August 22, 2025. time.com
Axios – ‘America’s doctors need more obesity medicine training,’ May 28, 2024. www.axios.com
Axios – ‘States slow to cover GLP-1s for weight loss’ (KFF policy report), November 5, 2024. www.axios.com
PharmaNewsIntelligence – ‘Psychiatrists Prescribe or Recommend Ozempic’ (survey data), November 6, 2023. forum.schizophrenia.com
California Board of Registered Nursing – AB 890 Implementation FAQ, Updated November 2024. www.rn.ca.gov
MedicalDirectorCo – ‘Texas Weight Loss Clinic & Telehealth Compliance Guide,’ 2025. www.medicaldirectorco.com
Wheel Health – ‘Florida Telehealth Regulations and Laws,’ 2022 (post-SB 312). www.wheel.com
SingleAim Health – ‘Nurse Practitioner Collaborative Agreement Templates 50-State Guide,’ 2023. www.singleaimhealth.com
Commonwealth of Pennsylvania – Press Release: ‘Shapiro Administration Expands Job Opportunities for Doctors and Nurses,’ June 23, 2025. www.pa.gov
American Association of Nurse Practitioners – State Practice Environment: Illinois, 2023. www.aanp.org
Rivkin Radler LLP – ‘New Law Allows Experienced NPs to Practice Independently in NY,’ April 2022. www.rivkinrounds.com
Florida Senate – Florida Statutes 2023, Section 464.0123 (APRN Autonomous Practice). www.flsenate.gov
CompHealth – ‘Interstate Medical Licensure Compact’ explainer, 2024. comphealth.com
Metabolic Mind Podcast – ‘Psychiatrist Shares His Experience with GLP-1 Weight Loss Drugs’ (Dr. Rodrigo Mansur interview). www.metabolicmind.org
Associated Press – ‘FDA says suicide warnings should be removed from Ozempic, Wegovy labels,’ February 2026. apnews.com
Science Direct – ‘Effects of flexible scheduling and telehealth on physician burnout’ (study on burnout mitigation), 2022. www.sciencedirect.com
TeleCare Aware – ‘GLP-1 telehealth and digital health trends’ (WeightWatchers acquisition), 2024. telecareaware.com
Axios – ‘Medicare and Medicaid eye coverage expansion for GLP-1 drugs,’ November 2025. www.axios.com
Find the right provider for your needs — select your state to find expert care near you.